guhjy's Takeuchi:M [20 articles] Export

Recent papers posted to guhjy's library by the author Takeuchi:M. You can also see everyone's Takeuchi:M.

	Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes. [My Copy] Diabetes, Vol. 55, No. 8. (August 2006), pp. 2245-2255. by Takuhito Shoji, Hidenori Koyama, Tomoaki Morioka, et al.Shinji Tanaka, Akane Kizu, Kohka Motoyama, Katsuhito Mori, Shinya Fukumoto, Atsushi Shioi, Noriko Shimogaito, Masayoshi Takeuchi, Yasuhiko Yamamoto, Hideto Yonekura, Hiroshi Yamamoto, Yoshiki Nishizawa posted to rage dn angiopoietin age by guhjy on 2009-11-29 10:16:55 as
	Irbesartan inhibits advanced glycation end product (AGE)-induced proximal tubular cell injury in vitro by suppressing receptor for AGEs (RAGE) expression. [My Copy] Pharmacological research : the official journal of the Italian Pharmacological Society (25 July 2009) by Takanori Matsui, Sho-Ichi I. Yamagishi, Masayoshi Takeuchi, Seiji Ueda, Kei Fukami, Seiya Okuda posted to rage pt arb age by guhjy on 2009-09-05 09:33:13 as
	High-sensitivity real-time imaging of dual protein-protein interactions in living subjects using multicolor luciferases. [My Copy] PloS one, Vol. 4, No. 6. (12 June 2009), e5868. by N. Hida, M. Awais, M. Takeuchi, et al.N. Ueno, M. Tashiro, C. Takagi, T. Singh, M. Hayashi, Y. Ohmiya, T. Ozawa posted to fca imaging ppi by guhjy on 2009-07-14 09:42:50 as along with 1 person neils
	Telmisartan inhibits advanced glycation end products (AGEs)-elicited endothelial cell injury by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gammaactivation. [My Copy] Protein and peptide letters, Vol. 15, No. 8. (2008), pp. 850-853. by S. Yamagishi, T. Matsui, K. Nakamura, M. Takeuchi, H. Inoue posted to arb endothelium pparg rage by guhjy on 2009-06-22 16:14:18 as
	Nifedipine, a calcium channel blocker, inhibits advanced glycation end product (AGE)-elicited mesangial cell damage by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation. [My Copy] Biochemical and biophysical research communications, Vol. 385, No. 2. (24 July 2009), pp. 269-272. by Takanori Matsui, Sho-ichi Yamagishi, Masayoshi Takeuchi, Seiji Ueda, Kei Fukami, Seiya Okuda posted to ros rage pparg mc ccb age by guhjy on 2009-06-21 02:50:33 as
	Independent determinants of soluble form of receptor for advanced glycation end products in elderly hypertensive patients. [My Copy] Metabolism: clinical and experimental, Vol. 58, No. 3. (March 2009), pp. 421-425. by K. Nakamura, H. Adachi, T. Matsui, Y. Kurita, M. Takeuchi, S. Yamagishi posted to aging bp srage rage by guhjy on 2009-06-18 16:08:41 as
	Microalbuminuria reduction with telmisartan in normotensive and hypertensive Japanese patients with type 2 diabetes: a post-hoc analysis of The Incipient to Overt: Angiotensin II Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) study. [My Copy] Hypertension research : official journal of the Japanese Society of Hypertension, Vol. 31, No. 4. (April 2008), pp. 657-664. by H. Makino, M. Haneda, T. Babazono, et al.T. Moriya, S. Ito, Y. Iwamoto, R. Kawamori, M. Takeuchi, S. Katayama, posted to arb bp japan normotensive rct telmisartan uae by guhjy on 2009-01-15 13:59:54 as
	An autoregressive linear mixed effects model for the analysis of longitudinal data which include dropouts and show profiles approaching asymptotes. [My Copy] Statistics in medicine, Vol. 27, No. 30. (30 December 2008), pp. 6351-6366. by T. Funatogawa, I. Funatogawa, M. Takeuchi posted to lmm longutudinal missing by guhjy on 2009-01-13 05:39:51 as
	Circannual rhythm of laboratory test parameters among chronic haemodialysis patients. [My Copy] Blood purification, Vol. 26, No. 2. (2008), pp. 196-203. by M. Yanai, A. Satomura, Y. Uehara, M. Murakawa, M. Takeuchi, K. Kumasaka posted to test hd diurnal by guhjy on 2008-06-28 05:30:55 as
	Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression. [My Copy] Microvasc Res, Vol. 75, No. 1. (January 2008), pp. 130-134. by S. Yamagishi, T. Matsui, K. Nakamura, et al.H. Inoue, M. Takeuchi, S. Ueda, K. Fukami, S. Okuda, T. Imaizumi posted to rage by guhjy on 2008-01-16 02:07:30 as
	Oral administration of AST-120 (Kremezin) is a promising therapeutic strategy for advanced glycation end product (AGE)-related disorders. [My Copy] Med Hypotheses, Vol. 69, No. 3. (2007), pp. 666-668. by S. Yamagishi, K. Nakamura, T. Matsui, H. Inoue, M. Takeuchi posted to no-tag by guhjy on 2008-01-14 12:00:24 as
	Telmisartan inhibits AGE-induced C-reactive protein production through downregulation of the receptor for AGE via peroxisome proliferator-activated receptor-gamma activation. [My Copy] Diabetologia, Vol. 49, No. 12. (December 2006), pp. 3094-3099. by T. Yoshida, S. Yamagishi, K. Nakamura, et al.T. Matsui, T. Imaizumi, M. Takeuchi, H. Koga, T. Ueno, M. Sata posted to rage by guhjy on 2007-10-23 10:12:47 as
	Nifedipine inhibits gene expression of receptor for advanced glycation end products (RAGE) in endothelial cells by suppressing reactive oxygen species generation. [My Copy] Drugs Exp Clin Res, Vol. 30, No. 4. (2004), pp. 169-175. by S. Yamagishi, M. Takeuchi posted to rage by guhjy on 2007-10-23 10:09:35 as
	Telmisartan, an angiotensin II type 1 receptor blocker, inhibits advanced glycation end-product (AGE)-induced monocyte chemoattractant protein-1 expression in mesangial cells through downregulation of receptor for AGEs via peroxisome proliferator-activated receptor-gamma activation. [My Copy] J Int Med Res, Vol. 35, No. 4. (g 2007), pp. 482-489. by T. Matsui, S. Yamagishi, S. Ueda, et al.K. Nakamura, T. Imaizumi, M. Takeuchi, H. Inoue posted to mc age arb mcp1 pparg rage by guhjy on 2007-10-23 10:08:26 as
	Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells. [My Copy] J Biol Chem, Vol. 277, No. 23. (7 June 2002), pp. 20309-20315. by S. Yamagishi, Y. Inagaki, T. Okamoto, et al.S. Amano, K. Koga, M. Takeuchi, Z. Makita posted to no-tag by guhjy on 2007-10-23 03:20:35 as
	Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes. [My Copy] Diabetes Metab Res Rev (10 August 2007) by Kazuo Nakamura, Sho-Ichi I. Yamagishi, Hisashi Adachi, et al.Takanori Matsui, Yayoi Kurita-Nakamura, Masayoshi Takeuchi, Hiroyoshi Inoue, Tsutomu Imaizumi posted to no-tag by guhjy on 2007-09-14 03:06:16 as
	Advanced glycation end products increase collagen-specific chaperone protein in mouse diabetic nephropathy. [My Copy] The Journal of biological chemistry, Vol. 279, No. 19. (7 May 2004), pp. 19816-19823. by Seiji Ohashi, Hideharu Abe, Toshikazu Takahashi, et al.Yasuhiko Yamamoto, Masayoshi Takeuchi, Hidenori Arai, Kazuhiro Nagata, Toru Kita, Hiroshi Okamoto, Hiroshi Yamamoto, Toshio Doi posted to age dn hsp hsp47 mouse by guhjy on 2007-09-13 09:45:22 as
	Advanced glycation end products inhibit de novo protein synthesis and induce TGF-beta overexpression in proximal tubular cells. [My Copy] Kidney Int, Vol. 63, No. 2. (February 2003), pp. 464-473. by S. Yamagishi, Y. Inagaki, T. Okamoto, S. Amano, K. Koga, M. Takeuchi posted to no-tag by guhjy on 2007-07-25 02:13:52 as
	AGEs activate mesangial TGF-beta-Smad signaling via an angiotensin II type I receptor interaction. [My Copy] Kidney Int, Vol. 66, No. 6. (December 2004), pp. 2137-2147. by K. Fukami, S. Ueda, S. Yamagishi, et al.S. Kato, Y. Inagaki, M. Takeuchi, Y. Motomiya, R. Bucala, S. Iida, K. Tamaki, T. Imaizumi, M. E. Cooper, S. Okuda posted to age at1 smad tgfb mc by guhjy on 2007-07-25 02:11:52 as
	RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin. [My Copy] Diabetes, Vol. 55, No. 9. (September 2006), pp. 2510-2522. by K. M. Myint, Y. Yamamoto, T. Doi, et al.I. Kato, A. Harashima, H. Yonekura, T. Watanabe, H. Shinohara, M. Takeuchi, K. Tsuneyama, N. Hashimoto, M. Asano, S. Takasawa, H. Okamoto, H. Yamamoto posted to dn heparin mouse rage by guhjy on 2007-07-05 03:10:50 as

Note: You may cite this page as: http://www.citeulike.org/user/guhjy/author/Takeuchi:M

ckd	1734
rct	1195
dn	1075
dm	997
cancer	980
ma	969
cv	905
hd	856
tgfb	791
snp	760
bp	633
ros	570
meta-analysis	515
uae	497
stats	476
kidney	473
software	458
mouse	453
genetics	444
mirna	442
pt	417
proteomics	409
mortality	408
inflammation	363
fbl	359
proteinuria	355
rat	355
pcr	348
tw	345
acei	330
db	326
gdl	325
test	325
urine	315
inhibitor	315
arb	312
ms	306
method	306
apoptosis	302
hcv	300
age	298
mc	294
r	291
aging	287
biomarker	285
irs	279
ppi	275
bias	274
akt	273
bayes	273
gwa	267
aki	265
mtor	263
aii	260
hg	257
nutrition	255
emt	242
rnai	242
ub	233
fibrosis	231
egfr	230
p53	230
cox	226
pbmc	220
smad	220
obesity	219
pi3k	213
metab	212
drug	211
hcc	210
gn	208
hypoxia	204
1	200
herb	197
albumin	189
erk	185
lc	185
collagen	180
hif	179
longitudinal	179
lmm	178
stz	175
nfkb	175
gfr	174
ua	170
pubmed	169
epigenetics	168
japan	165
gender	162
p38	162
cea	160
lead	159
power	159
rage	159
cadmium	158
dna-damage	156
bioinf	155
ref	154
genomics	148
stata	147
vitamin-d	146
ctgf	144
network	142
liver	138
screening	137
rt	135
diet	132
seq	131
company	129
protein	129
phosphorylation	127
go	125
systems-biology	124
pathway	122
cell-cycle	121
no	120
mt	120
pkc	117
book	117
esrd	117
lipid	117
creatinine	115
kinase	113
statin	113
senescence	106
podocyte	105
proliferation	104
mapk	103
fish	103
regression	103
pd	102
case-control	102
gfr-formula	102
imputation	101
s6k	101
cad	100
imaging	99
plasmid	97
rx	97
multiplicity	96
cloning	96
pediatric	95
p21	95
methylation	95
observational	95
recurrent	94
insulin	94
sirt	93
blood	91
nhanes	90
tnf	90
betel	90
nox	90
pparg	89
website	89
phenotype	88
toxicology	88
chf	88
cytokine	87
anemia	87
diagnosis	87
immunity	86
src	86
stat	85
uti	85
lr	84
at1	84
china	83
epo	82
nonp	81
p	81
oat	81
cachexia	80
hapmap	80
ca	79
ebm	79
environment	79
gout	78
primer	78
hypertrophy	78
review	75
qms	74
missing	73
gene-therapy	73
promoter	73
autophagy	73
ko	72
surrogate	72
lpd	72
eqtl	72
gene-list	72
mv	71
ace	71
salt	70
stone	69
egf	69
phd	69
cox2	68
signaling	68
uncertainty	66
mgo	66
tin	65
mirna-target	65
normalization	65
association	64
foxo	63
chinese	63
yeast	63
glycemia	63
causation	63
enddysf	63
acid-base	63
2dge	62
simulation	62
me	62
pla2	61
confounding	61
smoking	61
gpcr	61
hts	61
jnk	61
sas	60
pe	60
outcome	60
uuo	60
avf	60
ptm	60
melamine	60
change	60
oral	59
infection	59
eif	59
ifn	59
shc	59
cost	59
mmp	58
crp	58
alcohol	58
achr	57
pls	57
robust	57
llcpk1	57
pai1	57
urate-transporter	57
nrk49f	57
fluorescence	56
calibration	56
hk2	56
semantic	56
aceiarb	56
model-selection	56
hsp	56
pdgf	56
oglcnac	55
goldstd	55
ratio	55
competing-risk	55
function	54
bone	54
workflow	54
iron	54
estrogen	54
p-value	54
std	53
renoprotection	53
k	53
stem-cell	53
dipstick	53
ckd-progression	53
histone	52
qc	52
ncrna	52
rho	52
ace2	52
normoalbuminuria	51
vegf	51
pth	51
lod	51
atm	51
fgf	51
dimerization	51
epidemiology	51
cyclin-d1	50
risk-ratio	50
mercury	50
arsenic	50
reasoning	50
matlab	50
gene-environment	49
hsc	49
ab	49
antibiotics	49
graph	49
adpkd	49
tf	49
epistasis	49
klotho	48
nrk52e	48
breakpoint	48
pld	48
ukm	48
core-curriculum	48
ngal	47
spot-urine	47
pooling	47
mesangial	47
endothelium	47
protein-microarray	47
ffpe	47
joint-model	47
hdac	46
cystatin	46
aspirin	46
p27	46
4ebp	46
fdr	46
il6	46
ecm	46
hgf	46
biosensor	45
rapamycin	45
ras	45
aldosterone	45
fgf23	45
semip	45
writing	45
prevention	45
metal	45
ancova	44
wnt	44
variability	44
translation	43
interaction	43
bia	43
design	43
enos	43
sle	43
klf	43
cnv	43
na	43
dub	43
good	42
bmi	42
ccb	42
agreement	42
sumo	42
icu	42
roc	42
igf	41
stroke	41
tgfbr	41
diuretics	41
er-stress	41
alignment	40
risk	40
ampk	40
dbdb	40
wga	40
gene-targeting	40
fuzzy	40
qtl	39
hepatocyte	39
dry-bw	39
hyperfiltration	39
sage	38
ap1	38
urinalysis	38
protein-complex	38
igan	38
asia	38
myc	38
bh4	37
propensity	37
antisense	37
mtorc1	37
angiogenesis	37
animal	37
haplotype	37
tea	37
tlr	37
hematuria	37
fabp	37
adh	37
emr	36
cardiorenal	36
web20	36
catenin	36
rsk	36
megalin	36
omics	36
adenosine	36
inflammasome	36
s100b	35
cre	35
gsk	35
candidate-gene	35
subgroup	35
adduct	35
chemogenomics	35
annotation	35
calcification	34
sepsis	34
cross-species	34
reverse-epidemiology	34
msm	34
threshold	34
attrition	34
proteasome	34
pathology	34
sarcopenia	33
nephrotoxicity	33
coffee	33
sp1	33
zeb	33
fibronectin	33
exercise	33
snx	33
integrin	33
cage	33
rca	33
ns	33
effect-size	32
zfn	32
browser	32
text-mining	32
end-point	32
addgene	32
il1	32
affy	32
heritability	31
set	31
transactivation	31
hospitalization	31
fc	31
ecology	31
macrophage	31
blast	31
steroid	31
frailty	31
emsa	31
vsmc	31
gllamm	31
risk-difference	31
orbitrap	31
family	31
mw	30
staging	30
creb	30
bmp	30
notch	30
transporter	30
rtk	30
knockout	30
membrane-protein	30
abp	30
rvh	29
extraction	29
validation	29
nicotinic	29
3	29
et	29
nutrient	29
pka	29
grn	29
ai	29
s100	29
reporter	29
gee	28
mutagenesis	28
geo	28
scaling	28
acetylation	28
time-dependent	28
perindopril	28
race	28
ub-ligase	28
pdz	27
carcinogen	27
classification	27
thesis	27
cari	27
human	27
ndrd	27
ck2	27
mendelian	27
ce	27
spla2	27
agt	26
muscarinic	26
hba1c	26
metagenomics	26
mtorc2	26
hyaluronan	26
hplc	26
gsh	26
thp	26
silac	26
renin	26
prediction	25

guhjy's Takeuchi:M [20 articles] Export

guhjy's tags